12/16/21 4:21 PMAMEX : YCBD, YCBDPA earningsDue To Technical Difficulties, cbdMD, Inc. Moves Conference Call To Discuss September 30, 2021, Fourth Quarter and Fiscal Year Results To December 17, 2021 at 4:15 pm ESTcbdMD, Inc., one of the leading and most highly trusted and recognized CBD health& wellness companies, announced today that due to technical difficulties it will host its conference call at 4:15 p.m., Eastern Time, on Friday, December 17, 2021, to discuss the company’ s September 30, 2021 fourth quarter and fiscal year-end financial results and business progress.RHEA-AIneutral
12/01/21 8:30 AMAMEX, Nasdaq : YCBD, YCBDPA, PEP cbdMD Announces Hiring of Consumer Goods Veteran Dave Johnson To Drive FDM Distribution Channel & Business DevelopmentcbdMD, Inc., one of the leading, most highly trusted and best recognized CBD companies, announced the hiring of Dave Johnson as the Senior Vice President of Business Development. Mr. Johnson will be responsible for the Company’ s push into all major food, drug and mass merchandise retailers in the U.S. as well as creating new avenues for greater product distribution.RHEA-AIvery positive
11/29/21 8:30 AMAMEX, Nasdaq : YCBD, YCBDPA, AMZN partnershipcbdMD Announces Exclusive Multi-Year Partnership With Amazon Platform Partner AmifycbdMD, Inc., one of the leading, most highly trusted and best recognized CBD companies, today announced their multi-year exclusive agreement with Amify, an Amazon.com, Inc. platform partner, to prepare for the inclusion of CBD products within the Amazon marketplace. Amify, which specializes in Amazon go-to-market strategies, content creation and operational...RHEA-AIvery positive
06/28/21 6:30 PMNYSE : YCBD, YCBDPA cbdMD, Inc. Announces Pricing of $14.3 Million 8.0% Series A Cumulative Convertible Preferred Stock OfferingcbdMD, Inc. (NYSE American: YCBD, YCBDpA) today announced the pricing of its underwritten public offering of 1,913,100 shares of its 8.0% Series A Cumulative Convertible Preferred Stock at a price to the public of $7.50 per share. cbdMD expects to receive gross proceeds of $14,348,250 from theRHEA-AIneutral
